299 related articles for article (PubMed ID: 27328129)
1. Polymyxins: a new hope in combating Gram-negative superbugs?
Velkov T; Roberts KD; Thompson PE; Li J
Future Med Chem; 2016 Jun; 8(10):1017-25. PubMed ID: 27328129
[TBL] [Abstract][Full Text] [Related]
2. Discovery of Novel Polymyxin-Like Antibiotics.
Velkov T; Roberts KD
Adv Exp Med Biol; 2019; 1145():343-362. PubMed ID: 31364086
[TBL] [Abstract][Full Text] [Related]
3. Teaching 'old' polymyxins new tricks: new-generation lipopeptides targeting gram-negative 'superbugs'.
Velkov T; Roberts KD; Nation RL; Wang J; Thompson PE; Li J
ACS Chem Biol; 2014 May; 9(5):1172-7. PubMed ID: 24601489
[TBL] [Abstract][Full Text] [Related]
4. History, Chemistry and Antibacterial Spectrum.
Velkov T; Thompson PE; Azad MAK; Roberts KD; Bergen PJ
Adv Exp Med Biol; 2019; 1145():15-36. PubMed ID: 31364069
[TBL] [Abstract][Full Text] [Related]
5. Pharmacology of polymyxins: new insights into an 'old' class of antibiotics.
Velkov T; Roberts KD; Nation RL; Thompson PE; Li J
Future Microbiol; 2013 Jun; 8(6):711-24. PubMed ID: 23701329
[TBL] [Abstract][Full Text] [Related]
6. Reviving Polymyxins: Achievements, Lessons and the Road Ahead.
Li J
Adv Exp Med Biol; 2019; 1145():1-8. PubMed ID: 31364067
[TBL] [Abstract][Full Text] [Related]
7. Rescuing the Last-Line Polymyxins: Achievements and Challenges.
Nang SC; Azad MAK; Velkov T; Zhou QT; Li J
Pharmacol Rev; 2021 Apr; 73(2):679-728. PubMed ID: 33627412
[TBL] [Abstract][Full Text] [Related]
8. Development of new polymyxin derivatives for multi-drug resistant Gram-negative infections.
Brown P; Dawson MJ
J Antibiot (Tokyo); 2017 Apr; 70(4):386-394. PubMed ID: 28074057
[TBL] [Abstract][Full Text] [Related]
9. Polymyxins for CNS infections: Pharmacology and neurotoxicity.
Velkov T; Dai C; Ciccotosto GD; Cappai R; Hoyer D; Li J
Pharmacol Ther; 2018 Jan; 181():85-90. PubMed ID: 28750947
[TBL] [Abstract][Full Text] [Related]
10. Can octapeptin antibiotics combat extensively drug-resistant (XDR) bacteria?
Blaskovich MAT; Pitt ME; Elliott AG; Cooper MA
Expert Rev Anti Infect Ther; 2018 Jun; 16(6):485-499. PubMed ID: 29848132
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of phosphoethanolamine transferases involved in polymyxin resistance across 10 clinically relevant Gram-negative bacteria.
Huang J; Zhu Y; Han ML; Li M; Song J; Velkov T; Li C; Li J
Int J Antimicrob Agents; 2018 Apr; 51(4):586-593. PubMed ID: 29288722
[TBL] [Abstract][Full Text] [Related]
12. Rediscovering the octapeptins.
Velkov T; Roberts KD; Li J
Nat Prod Rep; 2017 Mar; 34(3):295-309. PubMed ID: 28180225
[TBL] [Abstract][Full Text] [Related]
13. Polymyxin derivatives: a patent evaluation (WO2012168820).
Wu H; Teng P; Niu Y; Li Q; Cai J
Expert Opin Ther Pat; 2013 Aug; 23(8):1075-81. PubMed ID: 23806121
[TBL] [Abstract][Full Text] [Related]
14. Polymyxins and their novel derivatives.
Vaara M
Curr Opin Microbiol; 2010 Oct; 13(5):574-81. PubMed ID: 20869908
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics/pharmacodynamics of colistin and polymyxin B: are we there yet?
Tran TB; Velkov T; Nation RL; Forrest A; Tsuji BT; Bergen PJ; Li J
Int J Antimicrob Agents; 2016 Dec; 48(6):592-597. PubMed ID: 27793510
[TBL] [Abstract][Full Text] [Related]
16. The renaissance of polymyxins.
Kadar B; Kocsis B; Nagy K; Szabo D
Curr Med Chem; 2013; 20(30):3759-73. PubMed ID: 23895690
[TBL] [Abstract][Full Text] [Related]
17. Polymyxin Derivatives that Sensitize Gram-Negative Bacteria to Other Antibiotics.
Vaara M
Molecules; 2019 Jan; 24(2):. PubMed ID: 30641878
[TBL] [Abstract][Full Text] [Related]
18. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections.
Falagas ME; Kasiakou SK
Clin Infect Dis; 2005 May; 40(9):1333-41. PubMed ID: 15825037
[TBL] [Abstract][Full Text] [Related]
19. A Novel Chemical Biology Approach for Mapping of Polymyxin Lipopeptide Antibody Binding Epitopes.
Velkov T; Yun B; Schneider EK; Azad MA; Dolezal O; Morris FC; Nation RL; Wang J; Chen K; Yu HH; Wang L; Thompson PE; Roberts KD; Li J
ACS Infect Dis; 2016 May; 2(5):341-51. PubMed ID: 27627202
[TBL] [Abstract][Full Text] [Related]
20. Polymyxins: Antibacterial Activity, Susceptibility Testing, and Resistance Mechanisms Encoded by Plasmids or Chromosomes.
Poirel L; Jayol A; Nordmann P
Clin Microbiol Rev; 2017 Apr; 30(2):557-596. PubMed ID: 28275006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
